30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Smith Sean Michael

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Smith Sean Michael's trades of Neurogene Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-04 2024-03-04
US Neurogene Inc (NGNE)
PrS Proposed sale
39,409
388.56
US$4,422,718 		39,409 388.56 US$4,422,718
2023-08-14 2023-08-11
US Neurogene Inc (NGNE)
PlS Planned sale
851 -16.1%
161.92
US$875,393 		851 -16.1% 161.92 US$875,393
2023-02-03 2023-02-02
US Neurogene Inc (NGNE)
S Sale
48,460 +28.7%
451.90
US$1,306,719 		48,460 +28.7% 451.90 US$1,306,719
2022-08-12 2022-08-10
US Neurogene Inc (NGNE)
S Sale
1,655 -19.6%
0.99
US$1,641 		1,655 -19.6% 0.99 US$1,641